Ivars Silamiķelis
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
Papers in
-
- Gut microbiota and health 11
- Metabolism, Diabetes, and Cancer 6
- Epigenetics and DNA Methylation 2
-
- Clostridium difficile and Clostridium perfringens research 5
- Co-authors
- Jānis Kloviņš (22 shared papers)Ilze Elbere (14 shared papers)Ineta Kalniņa (10 shared papers)Dāvids Frīdmanis (12 shared papers)Ilze Radoviča-Spalviņa (8 shared papers)Valdis Pīrāgs (8 shared papers)Ilze Konrāde (8 shared papers)Dita Gudrā (5 shared papers)
In The Last Decade
Ivars Silamiķelis
26 papers receiving 443 citations
Peers
Comparison fields: 5 of 87
- Biological Psychiatry 36
- Molecular Medicine 26
- Infectious Diseases 86
- Physiology 120
- Endocrinology, Diabetes and Metabolism 71
Countries citing papers authored by Ivars Silamiķelis
This map shows the geographic impact of Ivars Silamiķelis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivars Silamiķelis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivars Silamiķelis more than expected).
Fields of papers citing papers by Ivars Silamiķelis
This network shows the impact of papers produced by Ivars Silamiķelis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivars Silamiķelis. The network helps show where Ivars Silamiķelis may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivars Silamiķelis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 97 | |
| 2 | 2021 | 55 | |
| 3 | 2021 | 47 | |
| 4 | 2020 | 37 | |
| 5 | 2019 | 32 | |
| 6 | 2018 | 26 | |
| 7 | 2017 | 24 | |
| 8 | 2019 | 20 | |
| 9 | 2015 | 17 | |
| 10 | 2020 | 14 | |
| 11 | 2014 | 12 | |
| 12 | 2024 | 10 | |
| 13 | 2024 | 8 | |
| 14 | 2023 | 8 | |
| 15 | 2023 | 7 | |
| 16 | 2023 | 7 | |
| 17 | 2021 | 6 | |
| 18 | 2023 | 4 | |
| 19 | 2016 | 3 | |
| 20 | 2023 | 3 |
About Ivars Silamiķelis
Ivars Silamiķelis is a scholar working on Molecular Biology, Infectious Diseases, Genetics, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 27 papers that have together received 446 indexed citations. Recurring topics across this work include Gut microbiota and health (11 papers), Metabolism, Diabetes, and Cancer (6 papers), Clostridium difficile and Clostridium perfringens research (5 papers), Pituitary Gland Disorders and Treatments (4 papers), Diet and metabolism studies (4 papers), Mycobacterium research and diagnosis (3 papers), Genetic Associations and Epidemiology (3 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Biological Psychiatry (36 citations), Molecular Medicine (26 citations), Infectious Diseases (86 citations), Physiology (120 citations) and Endocrinology, Diabetes and Metabolism (71 citations). Ivars Silamiķelis has collaborated with scholars based in Latvia, Sweden and Denmark. Frequent co-authors include Jānis Kloviņš, Ilze Elbere, Ineta Kalniņa, Dāvids Frīdmanis, Ilze Radoviča-Spalviņa, Valdis Pīrāgs, Ilze Konrāde, Dita Gudrā, Linda Zaharenko and Monta Ustinova. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences, Frontiers in Endocrinology, Gut Microbes and Clinical Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.